Key result
Hypertriglyceridemic-waist phenotype linked to ~160% higher NAFLD risk vs normal waist and triglycerides.
Why the study?
The study sought to investigate the relationship between the hypertriglyceridemic-waist phenotype, a screening tool for cardiovascular and glycemic metabolic disease, and non-alcoholic fatty liver disease.
Is the hypertriglyceridemic-waist phenotype associated with an increased risk of non-alcoholic fatty liver disease in the general population?
Cross-Sectional (n=14,251)
No
Is the hypertriglyceridemic-waist phenotype associated with an increased risk of non-alcoholic fatty liver disease in the general population?
Answers are grounded in this paper and cite their sources.
The hypertriglyceridemic-waist phenotype is strongly associated with non-alcoholic fatty liver disease and may serve as a practical screening indicator.
BACKGROUND: Hypertriglyceridemic-waist (HTGW) phenotype has been proposed as a practical tool for screening the risk of cardiovascular diseases and glycemic metabolic disease. This study sought to investigate the relationship between HTGW phenotype and non-alcoholic fatty liver disease (NAFLD). METHODS: A total of 14,251 subjects who took part in health screening were enrolled in the study and NAFLD was diagnosed by abdominal ultrasound. According to triglyceride (TG) and waist circumference, the study population was divided into four phenotypes, in which HTGW phenotype was defined as TG ≥ 1.7 mmol/L and male waist circumference ≥ 90 cm or female waist circumference ≥ 80 cm. Multivariate logistic regression analysis was used to evaluate the relationship between HTGW phenotype and NAFLD. RESULTS: In the current study, 2.43% of the subjects had HTGW phenotype, while the prevalence of NAFLD in subjects with HTGW phenotype was 77.81%. After full adjustment for covariates, compared with people with normal waist circumference and TG levels, the risk of NAFLD in people with normal TG levels but enlarged waist circumference increased by 39% [OR:1.39, 95%CI: 1.15, 1.68], in people with normal waist circumference but elevated TG levels increased by 96% [OR:1.96, 95%CI: 1.65, 2.33], and in subjects with HTGW phenotype increased by 160% [OR:2.60, 95%CI: 1.88, 3.58]. Additionally, further analysis suggested that there were significant interactions between age, height, BMI and NAFLD risk associated with TGW phenotypes. Receiver operating characteristic curves analysis suggested that the combination of TG and waist circumference further improved the diagnostic value for NAFLD. CONCLUSIONS: HTGW phenotype is associated with NAFLD risk in the general population, which may be a novel and accessible indicator for NAFLD screening.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2022) conducted a cross-sectional in Non-alcoholic fatty liver disease (n=14,251). Hypertriglyceridemic-waist (HTGW) phenotype vs. Normal waist circumference and normal triglyceride levels (NTNW) was evaluated on Non-alcoholic fatty liver disease (NAFLD) (OR 2.60, 95% CI 1.88-3.58). The hypertriglyceridemic-waist phenotype was associated with a 160% increased risk of non-alcoholic fatty liver disease (OR 2.60) compared to individuals with normal waist circumference and triglycerides.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: